 |
 |
 |
 |
|
 |
Treatment Next 25
|
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
A Phase 1b Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Gliomas
|
 |
San Antonio, TX |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Phase 2a Study of AdV-tk + Valacyclovir Gene Therapy in Combination With Standard Radiation Therapy for Malignant Glioma |
 |
Duarte, CA Chicago, IL Columbus, OH San Antonio, TX |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
Anti-Tumor Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed Glioblastoma Multiforme During Recovery From Therapeutic Temozolomide-induced Lymphopenia |
 |
Durham, NC |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-Specific T-Cell Adoptive Transfer [ERaDICATe] |
 |
Durham, NC |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma |
 |
Los Angeles, CA |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients |
 |
Los Angeles, CA |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
 |
San Francisco, CA |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
PHASE II, Single-arm, Open-label Investigation of HSPPC-96 Vaccine With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme |
 |
San Francisco, CA |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
 |
Los Angeles, CA |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
Prospective, Phase II Clinical Trial to Evaluate Efficacy and Safety of Autologous Dendritic Cell Vaccination in Glioblastoma Multiforme Patients After Complete Surgical Resection With Fluorescence Microscope |
 |
Pamplona, SPAIN |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme |
 |
Durham, NC |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma) |
 |
Los Angeles, CA Los Angeles, CA |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
Phase I Study of Intratumoral and/or Resection Cavity Administration of Recombinant Measles Virus Encoding Human Carcinoembryonic Antigen in Patients With Recurrent Glioblastoma Multiforme |
 |
Rochester, MN |
 |
01/24/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
 |
Los Angeles, CA Los Angeles, CA Orange, CA Palo Alto, CA San Francisco, CA New Haven, CT Gainsville, FL Jacksonville, FL Atlanta, GA Iowa City, IA Chicago, IL Chicago, IL Evanston, IL Boston, MA Baltimore, MD Detroit, MI Lansing, MI Saginaw, MI Durham, NC Hackensack, NJ Buffalo, NY New York, NY New York, NY New York, NY Syracuse, NY Cleveland, OH Cleveland, OH Columbus, OH Philadelphia, PA Houston, TX San Antonio, TX Salt Lake City, UT Charlottesville, VA Seattle, WA |
 |
01/24/2010 |
 |
 |
 |
Details |
 |
A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma |
 |
Charleston, SC |
 |
01/14/2010 |
 |
 |
 |
 |
 |
Details |
 |
Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas |
 |
Bourgogne, France |
 |
01/14/2010 |
 |
 |
 |
Details |
 |
A Phase II study of Bevacizumab (Avastin) plus Temodar and Tarceva during and after Radiation Therapy in patients with newly diagnosed Glioblastoma or Gliosarcoma |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
 |
 |
Details |
 |
ABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
Details |
 |
ABTC05-02 - Phase I/II Studies of BAY 43-9006 (sorafenib) in Combination with OSI-774 (erlotinib), R115777 (tipifarnib) or CCI-779 (temsirolimus) in Patients with Recurrent Glioblastoma Multiforme or Gliosarcoma. |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Spectroscopy for Target Definition in Patients with Recurrent Glioma |
 |
San Francisco, CA |
 |
01/11/2010 |
 |
 |
 |
Details |
 |
Phase II Trial of Dasatinib in Patient with Recurrent Glioblastoma Multiforme |
 |
Cincinnati, OH |
 |
01/07/2010 |
 |
 |
 |
 |
 |
Details |
 |
A Study of Bevacizumab (Avastin) Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas |
 |
Cincinnati, OH |
 |
01/03/2010 |
 |
 |
 |
Details |
 |
A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma |
 |
Charleston, SC |
 |
12/30/2009 |
 |
 |
 |
 |
 |
Details |
 |
A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM) |
 |
Hershey, PA |
 |
12/30/2009 |
 |
 |
 |
Details |
 |
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma |
 |
Philadelphia, PA |
 |
12/30/2009 |
 |
 |
 |
 |
 |